Abstract
This comparative study by Gupta, et. al., found lower rates of post-operative diastasis and no hernia recurrence with Biodesign when compared to Alloderm.
Cook Biotech is now part of RTI Surgical.
See the press release about this acquisition for more information.
This comparative study by Gupta, et. al., found lower rates of post-operative diastasis and no hernia recurrence with Biodesign when compared to Alloderm.